Search | IOVS | ARVO Journals

Showing 1 – 18 of 18

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Leber’s Hereditary Optic Neuropathy visual field loss characterization by machine learning

Alice Galzignato; Catarina Coutinho; Ferdinando Zanchetta; Michele Carbonelli; Marco Battista; Giulia Amore; Valerio Carelli; Luigi Brotto; Paolo Nucci; Lisa Checchin; Giacomo Savini; Francesco Bandello; Chiara La Morgia; Maria Lucia Cascavilla; Rita Fioresi; Piero Barboni

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):87.

ARVO Annual Meeting Abstract June 2024

Assessment of Visual Field Loss Progression for DOA and Wolfram Syndrome employing a DOA- OPA1 Archetypal Analysis Model

Catarina Coutinho; Ferdinando Zanchetta; Michele Carbonelli; Alice Galzignato; Marco Battista; Giulia Amore; Valerio Carelli; Luigi Brotto; Paolo Nucci; Lisa Checchin; Giacomo Savini; Francesco Bandello; Chiara La Morgia; Rita Fioresi; Maria Lucia Cascavilla; Piero Barboni

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):86.

ARVO Annual Meeting Abstract June 2024

Optic nerve edema and pseudo-edema differentiation analysis using automated segmentation of fiber layer and blood vessels

Marco Battista; Jonathan Oakley; Michele Carbonelli; Catarina Coutinho; Alice Galzignato; Luigi Brotto; Giulia Amore; Lisa Checchin; Paolo Nucci; Leonardo Bottazzi; Valerio Carelli; Francesco Bandello; Chiara La Morgia; Maria Lucia Cascavilla; Piero Barboni

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):99.

ARVO Annual Meeting Abstract June 2024

From RCT to real wolrd 8 years experince with anti-VEGF for Type 1 ROP

Domenico Lepore; Lorenzo Orazi; Giulia Amorelli; Danilo Giovanni Giustino; Fernando Molle; Giuseppe M. Albanese

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1723.

ARVO Annual Meeting Abstract June 2023

Visual outcome in Leber’s hereditary optic neuropathy with asynchronous onset

Michele Carbonelli; Martina Romagnoli; Chiara La Morgia; Giulia Amore; Piero Barboni; Valerio Carelli

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4110.

ARVO Annual Meeting Abstract June 2023

Neuro-ophthalmological phenotype and correlations with heteroplasmy levels in MELAS and MERRF.

Giulia Amore; Michele Carbonelli; Martina Romagnoli; Fiorini Claudio; Leonardo Caporali; Chiara La Morgia; Valerio Carelli

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4107.

ARVO Annual Meeting Abstract June 2023

Optic nerve head morphology as biomarker in Leber hereditary optic neuropathy (LHON)

Alice Galzignato; Jonathan Oakley; Maria Lucia Cascavilla; Catarina P. Coutinho; Michele Carbonelli; Marco Battista; Alessandro Berni; Giorgio Lari; Giulia Amore; Chiara La Morgia; Enrico Borrelli; Francesco Bandello; Valerio Carelli; Piero Barboni

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4093.

ARVO Annual Meeting Abstract June 2022

Structural and functional ophthalmological follow-up of a preterm population: report at six years of age

Domenico Lepore; Benedetta Caproli; Lorenzo Orazi; giulia Amorelli; Francesca Gallini; Daniela Ricci; Lorenzo Hu; Federico Giannuzzi; Maria Petrianni; Filippo Amore; Giovanni Vento

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4177 – F0237.

Eye Movements, Strabismus, Amblyopia and Neuro-ophthalmology January 2022

Longitudinal Study of Optic Disk Perfusion and Retinal Structure in Leber's Hereditary Optic Neuropathy

PDF

Giacomo Calzetti; Chiara La Morgia; Marco Cattaneo; Arturo Carta; Francesca Bosello; Giulia Amore; Michele Carbonelli; Maria Lucia Cascavilla; Stefano Gandolfi; Valerio Carelli; Leopold Schmetterer; Hendrik P. N. Scholl; Piero Barboni
TAGS: longitudinal studies, optic atrophy, hereditary, leber, optic disk, perfusion, retina, vascular flow
Invest. Ophthalmol. Vis. Sci.. 2022; 63(1):43. https://doi.org/10.1167/iovs.63.1.43

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Pupillary light response and sleep-wake activity in preclinical Alzheimer’s disease

Angela Oh; Giulia Amore; William Sultan; Rustum Karanjia; Michael Harrington; Chiara La Morgia; Alfredo A Sadun

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6460.

ARVO Annual Meeting Abstract July 2019

Regression patterns of Retinopathy of Prematurity after intravitreal injection of Ranibizumab

Marco H. Ji; Darius Moshfeghi; Ryan A Shields; Zachary Bodnar; Cassie A. Ludwig; Natalia F. Callaway; Theodore Leng; Steven Sanislo; Lorenzo Orazi; Giulia Amorelli; Domenico Lepore

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6538.

ARVO Annual Meeting Abstract July 2019

Oct findings in a ROP population with brain lesions

Lorenzo Orazi; Giulia Maria Amorelli; Daniela Ricci; Fernando Molle; Domenico Lepore

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6523.

ARVO Annual Meeting Abstract July 2019

Optical coherence tomography evaluation of early foveal structural changes after anti-VEGF treatment for type 1 ROP.

Giulia Maria Amorelli; Lorenzo Orazi; Costanza Barresi; Fernando Molle; Domenico Lepore

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6534.

ARVO Annual Meeting Abstract July 2018

Laser versus Bevacizumab for Type-1 Retinopathy of Prematurity: FA vs OCT-A at 4 years of age

Domenico Lepore; Lorenzo Orazi; Marco H. Ji; Giulia Maria Amorelli; Fernando Molle; Graham E Quinn

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3755.

ARVO Annual Meeting Abstract July 2018

Long term follow-up of laser-treated severe Retinopathy of Prematurity: structural and functional findings

Marco H. Ji; Domenico Lepore; Lorenzo Orazi; Fernando Molle; Giulia Maria Amorelli

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3756.

ARVO Annual Meeting Abstract July 2018

OCT in acute phase Retinopathy of Prematurity

Lorenzo Orazi; Giulia Maria Amorelli; Domenico Lepore; Fernando Molle; Marco H. Ji

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2765.

ARVO Annual Meeting Abstract June 2017

Indications of mitochondrial dysfunction in Wolfram syndrome.

Chiara La Morgia; Michele Carbonelli; Leonardo Caporali; Francesca Tagliavini; Giulia Amore; federico sadun; Caterina Tonon; Ludovica Gramegna; Raffaele Lodi; Piero Barboni; Rocco Liguori; Valerio Carelli

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5132.

ARVO Annual Meeting Abstract June 2017

Sustained release intravitreal dexamethazone implant in the treatment of proliferative diabetic retinopathy and diabetic macular edema

Angelo M Minnella; matteo federici; Giulia Maria Amorelli; gloria gambini; VALERIA PAGLIEI; MARIA CRISTINA SAVASTANO; Benedetto Falsini; aldo caporossi

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):102.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Leber’s Hereditary Optic Neuropathy visual field loss characterization by machine learning

Assessment of Visual Field Loss Progression for DOA and Wolfram Syndrome employing a DOA- OPA1 Archetypal Analysis Model

Optic nerve edema and pseudo-edema differentiation analysis using automated segmentation of fiber layer and blood vessels

From RCT to real wolrd 8 years experince with anti-VEGF for Type 1 ROP

Visual outcome in Leber’s hereditary optic neuropathy with asynchronous onset

Neuro-ophthalmological phenotype and correlations with heteroplasmy levels in MELAS and MERRF.

Optic nerve head morphology as biomarker in Leber hereditary optic neuropathy (LHON)

Structural and functional ophthalmological follow-up of a preterm population: report at six years of age

Longitudinal Study of Optic Disk Perfusion and Retinal Structure in Leber's Hereditary Optic Neuropathy

Pupillary light response and sleep-wake activity in preclinical Alzheimer’s disease

Regression patterns of Retinopathy of Prematurity after intravitreal injection of Ranibizumab

Oct findings in a ROP population with brain lesions

Optical coherence tomography evaluation of early foveal structural changes after anti-VEGF treatment for type 1 ROP.

Laser versus Bevacizumab for Type-1 Retinopathy of Prematurity: FA vs OCT-A at 4 years of age

Long term follow-up of laser-treated severe Retinopathy of Prematurity: structural and functional findings

OCT in acute phase Retinopathy of Prematurity

Indications of mitochondrial dysfunction in Wolfram syndrome.

Sustained release intravitreal dexamethazone implant in the treatment of proliferative diabetic retinopathy and diabetic macular edema

To View More...

You must be signed into an individual account to use this feature.